FFP
IART icon

FourThought Financial Partners’s Integra LifeSciences IART Stock Holding History

FourThought Financial Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,520
Closed -$179K – 559
2025
Q3 		$179K Buy
+12,520
New +$172K 0.02% 486

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

FourThought Financial Partners's IART Position: Q4 2025 in Review

FourThought Financial Partners sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 12,520 shares — an estimated $179K sold.

FourThought Financial Partners first reported a position in IART in Q3 2025 and held it in 1 quarter. The position peaked at $179K in Q3 2025. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

  • FourThought Financial Partners reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
  • FourThought Financial Partners sold 12,520 Integra LifeSciences shares in Q4 2025, an estimated $179K.
  • FourThought Financial Partners first reported a position in Integra LifeSciences in Q3 2025 and held it in 1 quarter.
  • FourThought Financial Partners's Integra LifeSciences position peaked at $179K in Q3 2025.
  • 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on FourThought Financial Partners's 13F filing for Q4 2025, filed 6 Feb 2026.